Abstract
A simple stochastic recirculatory formalism is used to compare models of regional drug delivery due to Huntet al. and Boddy and Aarons. It is shown that these two models are equivalent when regional delivery is ideal. The latter model has the advantage of simplicity. However, the former model appears more useful in relating predictions to experimentally accessible quantities. Neither model is sufficiently general to cover all possible topologies of regions associated with drug response and toxicity. Knowledge of this topology is essential in determining the drug targeting index. The underlying assumptions of the models are discussed, and situations where these assumptions may break down are identified. Finally, it is noted that the analysis of regional delivery may also apply to metabolite and prodrug kinetics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. J. Stella and K. J. Himmelstein. Prodrugs and site-specific drug delivery.J. Med. Chem. 23: 1275–1282 (1980).
S. Øie and J.-D. Huang. The influence of administration route on drug delivery to a target organ.J. Pharm. Sci. 70: 1344–1347 (1981)
R. L. Dedrick. Interspecies scaling of regional drug delivery.J. Pharm. Sci. 75:1047–1052 (1986).
C. A. Hunt, R. D. MacGregor, and R. A. Siegel. Engineering targeted in vivo drug delivery. I: The physiological and physicochemical principles governing opportunities and limitations.Pharm. Res. 3:333–344 (1986).
G. Levy Targeted drug delivery—Some pharmacokinetic considerations.Pharm. Res. 4:3–4 (1987).
P. K. Gupta and C. T. Hung. Quantitative evaluation of targeted drug delivery systems.Int. J. Pharm. 56:217–226 (1989).
U. G. Eriksson and T. N. Tozer. Pharmacokinetic evaluation of regional drug delivery.Acta Pharm. Jug. 37:331–344 (1987).
A. Boddy, L. Aarons, and K. Petrak. Efficiency of drug targeting: Steady-state considerations using a three-compartment model.Pharm. Res. 6:367–372 (1989).
A. Boddy and L. Aarons. Application of a linear recirclation model to drug targeting.J. Pharmacokin. Biopharm. 19:355–362 (1991).
G. W. Roberts, K. B. Larson, and E. E. Spaeth. The interpretation of mean transit time measurements for multiphase tissue systems.J. theor. Biol. 39:447–475 (1973).
E. D. Trautman, Tracer measurements of non-equilibrium volumes of distribution.J. Theoret. Biol. 115:525–548 (1985).
M. Weiss. Moments of physiological transit time distributions and the time course of drug disposition in the body.J. Math. Biol. 15:305–318 (1982).
L. Bass, P. J. Robinson, and A. J. Bracken. Hepatic elimination of flowing substances: The distributed model.J. theor. Biol. 72:161–184 (1978).
A. B. Ahmad, P. N. Bennett, and M. Rowland. Models of hepatic drug clearance: Discrimination between the well-stirred and parallel-tube models.J. Pharm. Pharmacol. 35:219–224 (1983).
M. S. Roberts, and M. Rowland. Hepatic elimination-dispersion model.,J. Pharm. Sci. 74:585–587 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siegel, R.A., MacGregor, R.D. & Hunt, C.A. Comparison and critique of two models for regional drug delivery. Journal of Pharmacokinetics and Biopharmaceutics 19, 363–373 (1991). https://doi.org/10.1007/BF03036257
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03036257